|
Forecast
Period
|
2026-2030
|
|
Market
Size (2024)
|
USD
1.98 Billion
|
|
Market
Size (2030)
|
USD
3.07 Billion
|
|
CAGR
(2025-2030)
|
7.72%
|
|
Fastest
Growing Segment
|
FDS
|
|
Largest
Market
|
North
America
|
Market Overview
Global Flow Diversion Aneurysm Treatment
Market was valued at
USD 1.98 billion in 2024 and is anticipated to project impressive growth in the
forecast period with a CAGR of 7.72% through 2030. The Flow Diversion Aneurysm Treatment
Market is a rapidly evolving segment within the field of neurointerventional
procedures, driven by the imperative need to address cerebral aneurysms, a
potentially life-threatening condition. This market is characterized by the
innovative use of flow diversion devices, a minimally invasive treatment
approach designed to divert blood flow away from an aneurysm, promoting its
occlusion and reducing the risk of rupture. Continuous innovation in flow
diversion devices and neuroimaging techniques is expanding treatment options
and improving patient outcomes. The increasing incidence of cerebral aneurysms,
often associated with aging and other risk factors, fuels the demand for
effective treatments. Flow diversion procedures are less invasive compared to
traditional surgical approaches, resulting in reduced patient recovery times
and hospital stays. The global aging demographic is contributing to the
prevalence of cerebral aneurysms, elevating the demand for treatment. For instance, a 2023 article published in Science Direct explores the use of flow diversion therapy for treating intracranial aneurysms in a Peruvian patient cohort. The study highlights the challenges faced in a resource-limited setting, detailing clinical experiences, treatment outcomes, and significant barriers to implementing this advanced neurovascular intervention in underserved healthcare environments.
Expanding
healthcare infrastructure and access to specialized neurointerventional care
are enhancing patient access to flow diversion treatments. Rising awareness
about the consequences of untreated cerebral aneurysms and the availability of
advanced treatments is driving patient and physician interest. The Flow
Diversion Aneurysm Treatment Market is poised for continued growth as it offers
a compelling alternative to traditional surgical interventions, aligns with
minimally invasive healthcare trends, and addresses the pressing need to manage
cerebral aneurysms effectively. This market's trajectory reflects a commitment
to advancing patient care, reducing mortality rates, and improving the quality
of life for individuals at risk of aneurysm-related complications. In June 2022, Stryker and Carmeda formed a partnership to integrate their advanced flow diverter technologies with Carmeda’s active heparin coatings for the treatment of brain aneurysms. Stryker’s flow diverter, enhanced with Carmeda’s coating, effectively reduces thrombin—a key platelet activator and coagulation factor—demonstrating a significant reduction in clot formation in challenging bench models.
Key Market Drivers
Minimally invasive treatment
options
The Flow
Diversion Aneurysm Treatment Market is experiencing significant growth, driven
notably by the increasing adoption of minimally invasive treatment options.
This trend reflects a paradigm shift in the approach to managing cerebral
aneurysms, favoring less invasive procedures over traditional open surgeries.
Several key factors contribute to the prominence of minimally invasive options
in driving this market: Minimally invasive procedures involve smaller incisions
or access points, resulting in less tissue damage, reduced pain, and quicker
patient recovery times compared to open surgeries. This appeals to both
patients and healthcare providers. Minimally invasive flow diversion treatments
offer excellent patient outcomes, with lower complication rates and reduced
risks of infection or bleeding. This factor contributes to higher patient
satisfaction and a positive reputation for these procedures. Technological
advancements in medical devices and imaging techniques have made minimally
invasive treatments more precise and effective. The use of real-time imaging
guidance enhances the accuracy of flow diversion procedures.
Minimally
invasive treatments typically require shorter hospital stays, which reduces the
healthcare burden, lowers costs, and increases healthcare facility efficiency. The
less invasive nature of these procedures makes them accessible to a broader
patient population, including those who may not be suitable candidates for
traditional surgeries due to comorbidities. Both physicians and patients often
prefer minimally invasive options due to their safety profile, reduced
invasiveness, and quicker recovery, contributing to their growing popularity. As
minimally invasive techniques continue to advance and gain acceptance, they are
reshaping the landscape of cerebral aneurysm treatment. The Flow Diversion
Aneurysm Treatment Market benefits significantly from this trend as it aligns
with the goals of improving patient outcomes, enhancing quality of life, and
reducing the overall healthcare burden associated with aneurysm management.
Increasing prevalence of
cerebral aneurysms
The
Flow Diversion Aneurysm Treatment Market is experiencing robust growth,
propelled in large part by the increasing prevalence of cerebral aneurysms.
This medical condition, characterized by the weakening and ballooning of blood
vessels in the brain, poses a significant health risk and drives the demand for
effective treatment options. Several key factors contribute to this
prevalence-driven market expansion: The global aging demographic is a primary
contributor to the rising prevalence of cerebral aneurysms. As individuals age,
the structural integrity of blood vessels can weaken, increasing the likelihood
of aneurysm formation. Unhealthy lifestyle choices such as smoking, excessive
alcohol consumption, and a sedentary lifestyle are associated with an increased
risk of cerebral aneurysms. As these behaviors persist, the prevalence of
aneurysms continues to rise. Improved diagnostic techniques, such as advanced
neuroimaging and non-invasive screening, have enhanced the detection and
diagnosis of cerebral aneurysms. This increased detection has led to a higher
reported incidence of the condition. Growing awareness campaigns and healthcare
provider education have led to earlier detection and diagnosis of aneurysms,
increasing the overall number of cases identified. For instance, according to the Brain Aneurysm Foundation, approximately 6.8 million people in the U.S.—or about 1 in 50 individuals—live with an unruptured brain aneurysm. Each year, around 30,000 cases of ruptured brain aneurysms occur nationwide, equating to roughly one rupture every 18 minutes. As prevalence rises, the demand for effective treatments like flow diverters continues to grow.
Certain
genetic factors can increase an individual's susceptibility to developing
cerebral aneurysms, contributing to the prevalence of the condition, especially
within families with a history of aneurysms. As the prevalence of cerebral
aneurysms continues to rise, there is a growing need for effective treatment
options. Flow diversion procedures have emerged as a vital tool in managing
these conditions, offering patients a minimally invasive and highly effective
treatment choice. This prevalence-driven demand is expected to sustain the
growth of the Flow Diversion Aneurysm Treatment Market in the coming years.
Download Free Sample Report
Key Market Challenges
High procedural costs
High
procedural costs represent a significant challenge for the Flow Diversion
Aneurysm Treatment Market. These costs encompass various aspects of the
treatment process, including the price of flow diversion devices, hospital
fees, physician charges, and post-procedure care. Several factors contribute to
the elevated costs associated with flow diversion procedures: Flow diversion
devices, while effective, can be expensive. The cost of these specialized
implants used to divert blood flow away from the aneurysm can be a substantial
portion of the overall procedure expenses. Neurointerventional require
specialized training to perform flow diversion procedures safely and
effectively. This training incurs additional costs, including education and
certification. Patients who undergo flow diversion treatments often require
comprehensive pre-operative assessments, prolonged hospital stays, and
follow-up care. This complexity drives up healthcare costs.
Advancements
in technology and medical devices can lead to higher upfront costs, although
they may offer long-term benefits in terms of improved outcomes and reduced
complications. In some healthcare systems, reimbursement rates for flow
diversion procedures may not adequately cover the actual costs incurred by
hospitals and physicians, creating financial constraints. High procedural costs
can also pose financial challenges for patients, potentially limiting their
access to this advanced treatment option. Addressing the challenge of high
procedural costs in the Flow Diversion Aneurysm Treatment Market requires a
multi-faceted approach. This includes continued research and development to
optimize the cost-effectiveness of flow diversion devices, improved reimbursement
strategies, and efforts to expand access to specialized neurointerventional
care. Overcoming this challenge is essential to ensure that patients have
equitable access to life-saving treatment options while maintaining the
sustainability of healthcare systems.
Limited availability of
skilled neurointerventional.
The
limited availability of skilled neurointerventionalists poses a substantial
challenge to the Flow Diversion Aneurysm Treatment Market. Flow diversion
procedures require a high level of expertise and precision, and the scarcity of
trained neurointerventionalists can hinder patient access and the adoption of
these advanced treatments. Several factors contribute to this challenge: Neurointerventional
procedures, including flow diversion, demand specialized training and
experience that goes beyond standard medical education. Neurointerventionalists
need to be proficient in navigating complex vascular anatomy and utilizing
advanced imaging techniques.
The
number of neurointerventionalists is limited compared to the growing demand for
these procedures. This shortage results in longer wait times for patients
seeking treatment and geographic disparities in access to specialized care. Skilled
neurointerventionalists tend to be concentrated in urban or academic medical
centers, leaving patients in rural or underserved areas with limited access to
their expertise. High patient demand and a limited workforce can lead to heavy
workloads for neurointerventionalists, potentially contributing to burnout and
reducing the number of practitioners available to perform these procedures. The
extensive training required to become a neurointerventionalist, which often
spans several years, can deter medical professionals from pursuing this
specialty. Addressing the limited availability of skilled
neurointerventionalists in the Flow Diversion Aneurysm Treatment Market
necessitates efforts to expand training programs, promote the field as an
attractive career choice, and incentivize practitioners to work in underserved
areas. This challenge underscores the importance of investing in the
development and retention of specialized medical professionals to ensure that
patients have equitable access to life-saving flow diversion treatments.
Key Market Trends
Growing adoption of flow
diversion techniques
The growing
adoption of flow diversion techniques represents a significant trend in the
Flow Diversion Aneurysm Treatment Market. This trend is characterized by an
increasing preference among neurointerventionalists and patients for flow
diversion procedures as a primary method for managing cerebral aneurysms.
Several key factors contribute to the rising adoption of these techniques: Flow
diversion procedures are minimally invasive compared to traditional open
surgical approaches. This less invasive nature attracts patients seeking
treatments that offer shorter recovery times, reduced pain, and smaller
incisions.
Flow diversion
techniques have demonstrated high efficacy in treating complex, wide-necked,
and fusiform aneurysms that were once challenging to manage. This effectiveness
has led to increased trust and acceptance among both physicians and patients. Ongoing
advancements in flow diversion devices, including improved design, materials,
and delivery systems, have enhanced their safety and efficacy. These
innovations have encouraged wider adoption. Patients who undergo flow diversion
procedures often experience positive outcomes, with lower rates of aneurysm
recurrence and reduced risk of complications. These outcomes contribute to
patient satisfaction and confidence in the treatment. The expanding pool of
neurointerventionalists trained in flow diversion techniques has led to greater
availability of these procedures in medical centers worldwide. A growing body
of clinical evidence supports the effectiveness of flow diversion in preventing
aneurysm rupture, further driving adoption. According to the American Journal of Neuroradiology, the hospital treatment costs for endovascular coiling of an unruptured intracranial aneurysm in the U.S. significantly exceed Medicare reimbursements. The average hospital cost for surgical clipping is approximately USD 23,574, while endovascular coiling costs around USD 25,734—nearly USD 12,599 more than the average Medicare reimbursement.
Increased
patient awareness and education regarding treatment options have empowered
individuals to actively seek out flow diversion as a preferred treatment
choice. As the adoption of flow diversion techniques continues to rise, it is
likely to reshape the landscape of cerebral aneurysm management. This trend
aligns with the broader shift toward minimally invasive procedures in
healthcare and underscores the importance of ongoing research and development
to further enhance the safety and effectiveness of flow diversion treatments.
Advancements in neuroimaging
technologies
Advancements in
neuroimaging technologies are a prominent and transformative trend in the Flow
Diversion Aneurysm Treatment Market. These innovations encompass cutting-edge
imaging modalities and techniques that play a pivotal role in the planning,
execution, and post-procedure assessment of flow diversion procedures. Several
key factors underscore the significance of this trend:
Advanced
neuroimaging technologies enable clinicians to accurately characterize
aneurysms, including their size, location, morphology, and hemodynamic
properties. This precision is crucial for selecting the most appropriate flow
diversion device and planning the procedure. Real-time imaging guidance during
flow diversion procedures enhances the accuracy and safety of device placement.
Techniques such as fluoroscopy, 3D rotational angiography, and intraoperative
magnetic resonance imaging (MRI) provide dynamic visualization, ensuring
optimal device deployment. Post-procedure imaging allows clinicians to assess
the immediate results of flow diversion, confirm aneurysm occlusion, and detect
any complications. Non-invasive imaging modalities like CT angiography and MRI
play a vital role in monitoring patient progress.
Advanced imaging
facilitates personalized treatment strategies, as clinicians can tailor flow
diversion procedures based on aneurysm-specific characteristics. This
individualized approach enhances treatment outcomes and reduces the risk of
complications. Some modern imaging techniques, such as cone-beam CT, offer
improved image quality with lower radiation exposure, enhancing patient safety
during the procedure. Neuroimaging advancements drive research and development
efforts in the field, encouraging innovation in both imaging technologies and
flow diversion devices.
Patients benefit
from improved imaging, as it allows them to visualize and better understand
their condition and treatment plan, fostering informed decision-making. Overall,
advancements in neuroimaging technologies empower neurointerventional to
deliver safer, more precise, and personalized flow diversion treatments. This
trend not only elevates patient care but also contributes to the ongoing growth
and development of the Flow Diversion Aneurysm Treatment Market.
Segmental Insights
End User Insights
Hospitals play a dominant role in the Flow Diversion Aneurysm Treatment Market due to
several key factors that make them the primary setting for these complex
procedures. Hospitals, especially those equipped with specialized
neurointerventional departments or comprehensive stroke centers, have become
the preferred choice for patients and healthcare providers for flow diversion
aneurysm treatments. Here's why hospitals hold this dominant position: Hospitals
often house highly specialized teams of neurointerventionalists who possess the
expertise and experience required for performing flow diversion procedures.
These medical professionals are trained to navigate the intricacies of cerebral
anatomy and effectively deploy flow diversion devices.
Hospitals
are equipped with state-of-the-art neuroimaging facilities, including
angiography suites and intraoperative MRI or CT scanners. These advanced
technologies provide real-time guidance during procedures, enhancing precision
and safety. Hospitals offer comprehensive patient care, from pre-operative
evaluation to post-procedure monitoring and rehabilitation. This holistic
approach ensures that patients receive high-quality, coordinated care
throughout their treatment journey. In cases where aneurysms rupture or present
imminent danger, hospitals are equipped to provide emergency care and immediate
intervention, potentially saving lives. Hospitals have the infrastructure and
resources to handle the complexities of flow diversion procedures, including
access to operating rooms, specialized equipment, and intensive care units. Hospitals
are hubs for medical research and innovation, fostering ongoing advancements in
the field of neurointervention. This encourages the development of improved
flow diversion techniques and devices.
Patients
tend to trust hospitals as established healthcare institutions, making them
more likely to choose hospitals for complex procedures like flow diversion. In
summary, hospitals offer the comprehensive expertise, advanced technology, and
a multidisciplinary approach required for successful flow diversion aneurysm
treatments. Their role as the primary setting for these procedures underscores
the critical role they play in ensuring the safety and effectiveness of patient
care in the Flow Diversion Aneurysm Treatment Market.
Download Free Sample Report
Regional Insights
North
America has emerged as the dominant region in the Flow Diversion Aneurysm
Treatment Market for several compelling reasons, cementing its position as a
leader in neurointerventional care and innovation. The following factors elucidate
why North America plays a central role in this market: North America boasts a
robust and advanced healthcare infrastructure, with state-of-the-art hospitals,
specialized neurointerventional centers, and cutting-edge imaging facilities.
These resources are critical for the successful deployment of flow diversion
techniques. The region is home to a highly skilled and experienced
neurointerventional workforce, including neurosurgeons and interventional
radiologists, who are proficient in performing flow diversion procedures. Their
expertise ensures the safe and effective treatment of patients.
North
America is a global hub for medical innovation, with numerous research
institutions, universities, and medical device companies dedicated to advancing
neurointerventional technologies. This fosters ongoing research and
development, leading to the introduction of innovative flow diversion devices
and techniques. The region conducts extensive clinical research and trials in
the field of neurointervention, generating substantial clinical evidence
supporting the safety and efficacy of flow diversion procedures. Patients in
North America often seek the latest and most advanced medical treatments, and
they are more likely to be aware of flow diversion as a viable option for
aneurysm treatment. This drives demand and adoption.
North
America's high healthcare spending and insurance coverage contribute to
patients' access to specialized care, including flow diversion treatments. The
region has a well-established regulatory framework that ensures the safety and
effectiveness of medical devices, further instilling confidence in flow
diversion procedures. Overall, North America's leadership in the Flow Diversion
Aneurysm Treatment Market is a result of its comprehensive healthcare
ecosystem, a culture of medical innovation, and a highly skilled medical
workforce. These factors collectively position North America at the forefront
of neurointerventional care and propel the region's dominance in this critical
healthcare sector.
Recent Developments
In July 2023, MicroVention, Inc. partnered with U.S. physicians to successfully treat over 1,000 patients using the FRED X flow diverter. Designed for optimizing blood flow in small vessels, FRED X is the only FDA PMA-approved option with a 0.021" delivery system for smaller sizes and no distal lead wire. Enhanced with X Tech, it ensures precise and predictable placement. These advancements are expected to drive market growth in the near future.
In May 2023, Stryker acquired Cerus Endovascular Ltd., a company focused on developing medical devices for intracranial aneurysm treatment. Cerus Endovascular's CE-marked products, including the Neqstent coil-assisted flow diverter and Contour neurovascular system, will enhance Stryker’s existing portfolio of brain aneurysm treatments, strengthening its position in the neurovascular market.
In July 2023, MicroVention, Inc. partnered with U.S. physicians to successfully treat over 1,000 patients using the FRED X flow diverter. Engineered to optimize blood flow in small vessels, FRED X is the only FDA PMA-approved option with a 0.021" delivery system for smaller sizes and no distal lead wire. Enhanced with X Tech, it ensures precise and predictable placement.
- US
Food and Drug Administration (FDA) has approved a supplemental New Drug
Application (sNDA) for Roche's XofluzaTM (baloxavir marboxil) for the
Medications of acute, uncomplicated influenza, or flu in OCT 2019.
Key Market Players
- Acandis
GmbH
- BALT Group
- Cardinal Health Inc
- Endologix LLC
- Evasc Medical Systems Corp
- Imperative Care Inc
- InspireMD Inc
- Johnson and Johnson
- Lepu Medical Technology Beijing Co. Ltd
- Medtronic Plc
|
By
Product
|
By
End User
|
By
Region
|
- FDS
- Intrasaccular flow disruption devices
|
- Hospitals
- Specialty clinics
|
- North
America
- Europe
- Asia
Pacific
- South
America
- Middle
East & Africa
|
Report
Scope:
In
this report, the Global Flow Diversion Aneurysm Treatment Market has been
segmented into the following categories, in addition to the industry trends
which have also been detailed below:
- Flow Diversion Aneurysm Treatment Market, By Product:
o
FDS
o
Intrasaccular flow disruption devices
- Flow Diversion Aneurysm Treatment Market, By End User:
o
Hospitals
o
Specialty clinics
- Flow Diversion Aneurysm Treatment Market,
By Region:
o North America
§ United States
§ Canada
§ Mexico
o Europe
§ France
§ United Kingdom
§ Italy
§ Germany
§ Spain
o Asia-Pacific
§ China
§ India
§ Japan
§ Australia
§ South Korea
o South America
§ Brazil
§ Argentina
§ Colombia
o Middle East & Africa
§ South Africa
§ Saudi Arabia
§ UAE
Competitive
Landscape
Company
Profiles: Detailed
analysis of the major companies present in the Flow Diversion Aneurysm
Treatment Market.
Available
Customizations:
Global
Flow Diversion Aneurysm Treatment market report with the given market
data, TechSci Research offers customizations according to a company's specific
needs. The following customization options are available for the report:
Company
Information
- Detailed analysis and profiling of
additional market players (up to five).
Global
Flow Diversion Aneurysm Treatment Market is an upcoming report to be released
soon. If you wish an early delivery of this report or want to confirm the date
of release, please contact us at [email protected]